Dhiman Vikas
Department of Neurology, Ivy Hospital, Panchkula, Haryana, India.
Ann Indian Acad Neurol. 2017 Apr-Jun;20(2):96-102. doi: 10.4103/aian.AIAN_447_16.
Epilepsy is a common neurological problem, and there is a genetic basis in almost 50% of people with epilepsy. The diagnosis of genetic epilepsies makes the patient assured of the reasons of his/her seizures and avoids unnecessary, expensive, and invasive investigations. Last decade has shown tremendous growth in gene sequencing technologies, which have made genetic tests available at the bedside. Whole exome sequencing is now being routinely used in the clinical setting for making a genetic diagnosis. Genetic testing not only makes the diagnosis but also has an effect on the management of the patients, for example, the role of sodium channels blockers in + Dravet syndrome patients and usefulness of ketogenic diet therapy in + generalized epilepsy patients. Many clinicians in our country have no or limited knowledge about the molecular genetics of epilepsies, types of genetic tests available, how to access them and how to interpret the results. The purpose of this review is to give an overview in this direction and encourage the clinicians to start considering genetic testing as an important investigation along with electroencephalogram and magnetic resonance imaging for better understanding and management of epilepsy in their patients.
癫痫是一种常见的神经问题,近50%的癫痫患者存在遗传基础。遗传性癫痫的诊断可让患者明确其癫痫发作的原因,避免不必要、昂贵且具有侵入性的检查。过去十年,基因测序技术取得了巨大发展,使得床边基因检测成为可能。目前,全外显子组测序已在临床常规用于基因诊断。基因检测不仅有助于诊断,还对患者的治疗管理产生影响,例如,钠通道阻滞剂在Dravet综合征患者中的作用以及生酮饮食疗法在全身性癫痫患者中的效用。我国许多临床医生对癫痫的分子遗传学、可用的基因检测类型、如何获取检测以及如何解读结果了解甚少或了解有限。本综述旨在就此方向进行概述,并鼓励临床医生开始将基因检测视为与脑电图和磁共振成像同样重要的检查手段,以便更好地理解和管理患者的癫痫病情。